Liver Cancer

With earlier diagnosis, the prognosis of those with liver cancer is greatly improved. Our VeraMarker™ metabolite profiling enables early, more accurate diagnosis.

Learn More »


Metabolite Profiling

The need for improved cancer diagnostics is compelling. Yet molecular diagnostics employing DNA, RNA, and proteins have not delivered as expected with actionable clinical tests.

Learn More »


Investor Ready

Matrix-Bio is seeking investor support to validate its potentially clinically superior VeraMarker™ Liver Cancer Screening test and VeraMarker™ Colon Cancer Monitoring test.

Learn More »